Other languages Granules India Limited NSE India S.E.

Equities

GRANULES

INE101D01020

Market Closed - NSE India S.E. Other stock markets 07:43:48 2024-05-10 EDT			5-day change	1st Jan Change
398 ^INR	+1.52%		-5.98%	-1.83%

04-30	Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares	MT
04-15	Granules India Gets Zero Observation from US FDA After Inspection of Visakhapatnam, India Unit	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Granules Pharmaceuticals Arm Gets US FDA's Approval for Generic Drug for Gout Flares	04-30
Granules India Unit Gets VAI Status for Virginia Facility	04-03
Granules India Limited Announces Appointment of Directors	04-02
Granules India Limited Announces Cessation of Arun Rao Akinepally as Independent Director	03-29
Granules India Limited Announces Appointment of Sethu Madhavan Sankaran as Senior Vice President - Api Manufacturing & Operations	03-29
Granules India Limited Appoints Atul Dhavle as Chief Human Resources Officer	03-11
Granules India Limited Announces That J. Shravan Reddy Shall Cease to Be Senior Vice President & Head- API Manufacturing	03-05
Paracetamol maker Granules India posts marginal rise in Q3 profit	01-23
Granules India's Posts Gains in Fiscal Q3 Consolidated Net Profit	01-23
Granules India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	01-23
Granules Pharmaceuticals Unit's Virginia Facility Gets Five Observations from US FDA	12-18
Granules India Gets US FDA Nod for Pantoprazole Sodium Delayed-Release Tablets	12-13
Granules India Limited Receives ANDA Approval for Pantoprazole Sodium Delayed-Release Tablets	12-13
Granules India Arm Gets US FDA Nod for Sildenafil for Oral Suspension	12-03
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	11-09
Granules India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-09
Granules India Gets US FDA's Approval for Generic Drug for GERD Symptoms	23-10-19
Granules India Limited Receives ANDA Approval for Esomeprazole Magnesium Delayed-Release Capsules	23-10-19
Indian paracetamol maker Valiant Laboratories lists at 16% premium	23-10-06
Granules India Gets US FDA Nod for Hypertension Treatment Drug	23-10-01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Granules India Limited NSE India S.E.

Equities

GRANULES

INE101D01020

Other languages

Filters